Kimberly-Clark Corporation (KMB) M&A Call Transcript

Good morning. Welcome to today's conference call to discuss Kimberly-Clark's acquisition of Kenvue. [Operator Instructions]. With that, I would now like to turn the call over to Chris Jakubik, ...

Vertex Announces Third Quarter 2025 Financial Results and $150 Million Class A Common Stock Repurchase Program

Vertex, Inc. (NASDAQ: VERX) (“Vertex” or the “Company”), a leading global provider of indirect tax solutions, today announced financial results for its third quarter ended September 30, 2025 and the ...

Ares Management Corporation (ARES) Q3 2025 Earnings Call Transcript

Q3 2025 Earnings Call November 3, 2025 9:00 AM ESTCompany ParticipantsGreg Mason - Managing Director of Public IR ...

Vertex Inc.: Vertex Announces Third Quarter 2025 Financial Results and $150 Million Class A Common Stock Repurchase Program

Vertex, Inc. (NASDAQ: VERX) ("Vertex" or the "Company"), a leading global provider of indirect tax solutions, today announced financial results ...
China Daily Global Edition

Federal workers feel squeeze for food during shutdown

Even though the shutdown may not significantly affect the US economy as a whole, Pacitti noted that it disproportionately ...
Medscape

Brensocatib’s Benefits Extend to Lung Structure

The first-in-class drug for bronchiectasis shows promise beyond reduced exacerbations and improved lung function.

Vertex (VERX) Q3 2025 Earnings Call Transcript

The strength of our strategy was evident in our strong cloud revenue growth, the increased margin leverage driven by ...

Solid Biosciences Reports Third Quarter 2025 Financial Results and Provides Update on INSPIRE DUCHENNE Clinical Trial Progress and Planned Regulatory Discussions

Duchenne (SGT-003): 23 participants have been dosed in the INSPIRE DUCHENNE trial as of October 31, 2025; Solid expects to ...

Tisento Therapeutics Announces Publication of MELAS Interview Study, Incorporating Patients’ Perspectives to Elucidate Symptoms and Impacts of Rare Mitochondrial Disease

Tisento Therapeutics today announced that the findings from the company’s interview study in MELAS (Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-like Episodes) were published on ...
The Manila Times

Beam Therapeutics to Present Updated Data from BEACON Phase 1/2 Trial of BEAM-101 in Sickle Cell Disease at American Society of Hematology (ASH) Annual Meeting

Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced that the company will present updated safety and efficacy ...
Le Lézard

IGC Pharma Expands AI-Powered Drug Discovery In-Silico Pipeline

POTOMAC, MARYLAND / ACCESS Newswire / November 3, 2025 / IGC Pharma, Inc. ("IGC Pharma," "IGC," or the "Company") , a clinical-stage biotechnology company leveraging AI to develop innovative ...
Scientific Research Publishing

The Exploration of the Effects of Art Therapy on Individuals’ Psychological Recovery Mechanisms under the Chinese Cultural Context ()

Art therapy in China emerged during the 1990s and is still in its early stage of cultural adaptation and methodological refinement. This study explores the development and application of art therapy ...